Subscribe to Ophthalmology
View Sample

FREE Email Newsletter

Photos of the Day: Ultrasound Eye Imaging ... in Space

December 12, 2013 9:36 am | by NASA | News | Comments

Mice were flown aboard shuttle flights STS-133 in March 2011 and STS-135 in July 2011 as part of the Commercial Biomedical Testing Module-2 (CBTM-2) and CBTM-3 investigations into how space affects ...         

Orbital Samples with Sight-Saving Potential

December 12, 2013 9:33 am | by Laura Niles, NASA/Johnson Space Center | News | Comments

Those who travel to space are rewarded with a beautiful sight - planet Earth. But the effects of space travel on the human sense of sight aren't so beautiful. More than 30 percent of astronauts who returned from two-week space shuttle missions and 60 percent who spent six months aboard the International Space Station were diagnosed with ...

Development of Sensors to Aid the Blind

December 11, 2013 1:03 pm | by University of Wollongong | News | Comments

Researchers from UOW have advanced our understanding of the most effective echolocation techniques, which could be used to develop better navigation aids for the blind and to create high-tech robots to rescue people from disaster scenes. Robotics...


The Ten Biggest Medical Successes of 2013

December 11, 2013 9:41 am | by PR Newswire | News | Comments

"One of These Rivals the Original Proof that Penicillin Works," Says Medical Trend Guru Stephen Shrewsbury. Medical science had a banner year in 2013, including a development, according to Dr. Stephen Shrewsbury, that offers the first long...

Innovative Drug-Dispensing Contact Lens Delivers Glaucoma Medication Continuously for a Month

December 9, 2013 11:24 am | by Massachusetts Eye and Ear Infirmary | News | Comments

For nearly half a century, contact lenses have been proposed as a means of ocular drug delivery that may someday replace eye drops, but achieving controlled drug release has been a significant challenge. Researchers at Massachusetts Eye and...

UK regulators OK pSivida's Iluvien

December 4, 2013 10:49 am | by Mass Device | News | Comments

pSivida said the UK's National Institute for Health & Care Excellence approved its Iluvien drug/device combination. The approval is for cataract surgery patients who don't respond to standard treatment for diabetic macular edema, according...

Scientists Design and Test New Approach for Corneal Stem Cell Treatments

November 27, 2013 11:08 am | by Cedars-Sinai Medical Center | News | Comments

Researchers in the Cedars-Sinai Regenerative Medicine Institute have designed and tested a novel, minute-long procedure to prepare human amniotic membrane for use as a scaffold for specialized stem cells that may be used to treat some corneal...

Avalanche Biotechnologies raises $5.7M for eye treatment

November 27, 2013 10:16 am | by Mass Device | News | Comments

Avalanche Biotechnologies said it raised nearly $5.7 million of a hoped-for $6.1 million equity round for the age-related macular degeneration treatment it's developing. The Avalanche technology is a drug-delivery system designed to trigger...


Funding: French retinal implant maker Pixium Vision raises $20M

November 26, 2013 1:03 pm | by Mass Device | News | Comments

Retinal implants maker Pixium landed a $20.3 million (€15 million) Series A funding round, planning to use the funds to further develop its IRIS "bionic eye" technology. The IRIS system is comprised of a retinal implant and a pair of camera-mounted...

Designing With the Blind in Mind

November 18, 2013 11:40 am | by TED | Videos | Comments

What would a city designed for the blind be like? Chris Downey is an architect who went suddenly blind in 2008; he contrasts life in his beloved San Francisco before and after -- and shows how the thoughtful designs that...    

New Diagnostic and Surgical Innovations and Data Management Solutions from ZEISS

November 16, 2013 10:22 pm | by Business Wire | News | Comments

US Introduction of FORUM Glaucoma Workplace from ZEISS ZEISS announces the US release of a new glaucoma diagnostic and management software application, FORUM Glaucoma Workplace, at the 2013 Annual Meeting of the American Academy of Ophthalmology...

NIH Study Finds Patients at High-Risk for Developing Neovascular Age-Related Macular Degeneration Benefit from ForeseeHome Monitoring for Early Detection of CNV

November 16, 2013 12:01 am | by The Associated Press | News | Comments

The results of the Home Monitoring of the Eye (HOME) study, conducted in Age-Related Eye Disease Study 2 (AREDS2) clinical centers, executed by the EMMES Corporation and sponsored by Notal Vision Ltd. Tel Aviv, Israel, have been accepted for...

Study: Donor Age Not a Factor in Most Corneal Transplants

November 15, 2013 5:19 pm | by NIH/National Eye Institute | News | Comments

Ten years after a transplant, a cornea from a 71-year-old donor is likely to remain as healthy as a cornea from a donor half that age, according to a study funded by the National Institutes of Health. Corneas from donors over age 71 perform...


Lumenis wins U.S. & Japanese clearance for retinal laser treatment

November 15, 2013 1:28 pm | by Mass Device | News | Comments

Lumenis Ltd. announced today regulatory wins in the U.S. and Japan for its Array LaserLink pattern scanning device for multi-spot laser photocoagulation for use during retinal surgery. The Array LaserLink, which turns an "examination slit lamp"...

FDA lowers regulatory oversight of scleral plugs for eye surgery

November 15, 2013 12:28 pm | by Mass Device | News | Comments

The FDA this week issued its final rule on scleral plugs, down-classifying them to a lower-risk category of medical devices in need of less stringent review. The FDA ruled to move the plugs to Class II, 510(k) premarket notification with special...

Cataract Surgery Saves $123.4 Billion in Direct, Indirect Costs

November 15, 2013 11:05 am | by American Academy of Ophthalmology | News | Comments

Cataract surgeries performed over one year eventually save $123.4 billion over 13 years and delivers a 4,567 percent financial return on investment to society according to the results of a cost-utility study, published online today in the Academy's...

Eye Foundation of America's "100,000 Lives" Campaign Reaches Early Milestone with Mobile Diabetic Diagnostics

November 15, 2013 10:42 am | by PR Newswire | News | Comments

The Eye Foundation of America announced today, that its $1 million, "100,000 Lives" campaign has reached an early milestone through the development of a diabetic diagnostic mobile unit housed with the latest in innovative diagnostic technology...

Photos of the Day: Restoring Sight

November 15, 2013 9:37 am | by Florida International University | News | Comments

A tiny video camera mounted on special glasses captures the scene in the patient’s environment, and a pocket controller relays the captured video signal to the implant. Inspired by cochlear implants that can restore hearing to some deaf people...

Retinal Implant Could Restore Sight for the Blind

November 15, 2013 9:29 am | by James Hellegaard, Florida International University | News | Comments

People who went blind as a result of certain diseases or injuries may have renewed hope of seeing again thanks to a retinal implant developed with the help of FIU’s W. Kinzy Jones, a professor and researcher in the College of Engineering and...

Study: Your Brain Sees Things You Don’t

November 14, 2013 2:37 pm | by Shelley Littin, University of Arizona | News | Comments

A new study by UA doctoral student Jay Sanguinetti indicates that our brains perceive objects in everyday life of which we may never be aware. The finding challenges currently accepted models about how the brain processes visual information...

Second Sight Medical Products’ Argus II Named Invention of the Year by Popular Science Magazine

November 13, 2013 11:08 am | by Business Wire | News | Comments

Second Sight Medical Products, Inc., the leading developer of retinal prostheses for the blind, is pleased to announce that its Argus II Retinal Prosthesis System (Argus II), has been recognized by Popular Science magazine as ‘Invention of the Year.’

Biolase tanks on gaping Q3 losses, fires sales & marketing veeps, will seek acquirer

November 12, 2013 12:15 pm | by Mass Device | News | Comments

Biolase shares plunged today after the medical device company said it's headed for the auction block, having seen its 3rd-quarter losses widen by a whopping 639% and sacked its sales and marketing heads after badly missing Wall Street's earnings...

Avedro Announces the Start of Two New US FDA Trials for Accelerated Cross-linking

November 12, 2013 12:01 am | by The Associated Press | News | Comments

Avedro Inc., a Boston-based ophthalmic medical device and pharmaceutical company, announces today that the first patients have been treated in two new US clinical trials: Lasik with Cross-linking and Pulsed Accelerated Cross-linking. Lasik with...

Breakthrough in Retinal Implants Expected to Restore Sight to the Blind

November 11, 2013 2:49 pm | by Pete Brown, University of Arizona | News | Comments

Researchers at the University of Arizona and University of Tübingen have made a breakthrough in retinal implant technology that could help people who have lost their sight see more than just light and vague shapes. Wolfgang Fink, an associate...

Retinal Neurons Research Could Lead to Regenerative Therapies for the Brain

November 1, 2013 10:12 am | by Virginia Tech | News | Comments

Real estate agents emphasize location, location, and – once more for good measure – location. It's the same in a developing brain, where billions of neurons vie for premium property to make connections. Neurons that stake out early claims often...

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.